
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
解锁市场时间线与信号动态
最近 90 天内有 154 个信号。
该公司进入各个市场的顺序 — 从最早到最新
89 active postings
48 active postings
注册以查看完整信号动态
Bristol Myers Squibb 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
Bristol Myers Squibb你 | 22 | 2 | +40% | 139 | 36 |
Senior Manager, Commercial AI & Digital Solutions
查看职位Seoul, Seoul, South Korea · 昨天
EG-090 - Clinical Research Associate
查看职位Beijing, Beijing, China · 昨天
Director, Data Engineering & Analytics
查看职位Devens, MA · 上周
Hiring Now: Advance Meaningful Work in Clinical Trials
已结束Drive Analytics That Shape Global Research
已结束Hiring Now: Join the Future of Neuroscience
已结束和铂医药任命Adam Zong博士为总裁,负责加强产品管线、推进组合策略及领导合作伙伴关系。Zong拥有超过20年生物制药经验,曾任职默克、百时美施贵宝、辉瑞及恒瑞医药。
纽交所提供开市前更新,包括英伟达盈利、汉堡王AI助手、以及即将与Lumen和Phinia CEO进行的NYSE Live访谈。
三分之一的风湿病专家认为BMS的Sotyktu是银屑病关节炎治疗的重大进展,具有强烈的上市前认知度,并在安全性方面与JAK抑制剂有所区别。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Bristol Myers Squibb 的业务、市场和增长信号的快速解答。
